Patient-centered outcomes of a value-based insurance design program for patients with diabetes
- PMID: 23405873
- DOI: 10.1089/pop.2012.0031
Patient-centered outcomes of a value-based insurance design program for patients with diabetes
Abstract
Value-based insurance design (VBID) initiatives have been associated with modest improvements in adherence based on evaluations of administrative claims data. The objective of this prospective cohort study was to report the patient-centered outcomes of a VBID program that eliminated co-payments for diabetes-related medications and supplies for employees and dependents with diabetes at a large health system. The authors compared self-reported values of medication adherence, cost-related nonadherence, health status, and out-of-pocket health care costs for patients before and 1 year after program implementation. Clinical metrics and satisfaction with the program also are reported. In all, 188 patients completed the follow-up evaluation. Overall, patients reported a significant reduction in monthly out-of-pocket costs (P<0.001), which corresponded to a significant reduction in cost-related nonadherence from 41% to 17.5% (P<0.001). Self-reported medication adherence increased for hyperglycemic medications (P=0.011), but there were no apparent changes in glycemic control. Overall, 89% of participants agreed that the program helped them take better care of their diabetes. The authors found that a VBID program for employees and dependents with diabetes was associated with self-reported reductions in cost-related nonadherence and improvements in medication adherence. Importantly, the program was associated with high levels of satisfaction among participants and strongly perceived by participants to facilitate medication utilization and self-management for diabetes. These findings suggest that VBID programs can accomplish the anticipated goals for medication utilization and are highly regarded by participants. Patient-centered outcomes should be included in VBID evaluations to allow decision makers to determine the true impact of VBID programs on participants.
Similar articles
-
The impact of a value-based insurance design plus health coaching on medication adherence and medical spending.Popul Health Manag. 2015 Jun;18(3):151-8. doi: 10.1089/pop.2014.0081. Epub 2014 Sep 23. Popul Health Manag. 2015. PMID: 25247449
-
Value-based insurance design program in north Carolina increased medication adherence but was not cost neutral.Health Aff (Millwood). 2014 Feb;33(2):300-8. doi: 10.1377/hlthaff.2013.0260. Health Aff (Millwood). 2014. PMID: 24493774
-
The effect of a large regional health plan's value-based insurance design program on statin use.Med Care. 2012 Nov;50(11):934-9. doi: 10.1097/MLR.0b013e31826c8630. Med Care. 2012. PMID: 23047782
-
Value-based insurance design: quality improvement but no cost savings.Health Aff (Millwood). 2013 Jul;32(7):1251-7. doi: 10.1377/hlthaff.2012.0902. Health Aff (Millwood). 2013. PMID: 23836741 Review.
-
Perspectives in value-based insurance design for patients with diabetes: assessment and application.Am Health Drug Benefits. 2011 Jan;4(1):27-33. Am Health Drug Benefits. 2011. PMID: 25126335 Free PMC article. Review.
Cited by
-
Association of Participation in a Value-Based Insurance Design Program With Health Care Spending and Utilization.JAMA Netw Open. 2023 Mar 1;6(3):e232666. doi: 10.1001/jamanetworkopen.2023.2666. JAMA Netw Open. 2023. PMID: 36912835 Free PMC article.
-
Cost-sharing and adherence, clinical outcomes, health care utilization, and costs: A systematic literature review.J Manag Care Spec Pharm. 2023 Jan;29(1):4-16. doi: 10.18553/jmcp.2022.21270. Epub 2022 Apr 7. J Manag Care Spec Pharm. 2023. PMID: 35389285 Free PMC article. Review.
-
A Scoping Review of Behavioral Interventions Addressing Medical Financial Hardship.Popul Health Manag. 2021 Dec;24(6):710-721. doi: 10.1089/pop.2021.0043. Epub 2021 May 14. Popul Health Manag. 2021. PMID: 33989065 Free PMC article. Review.
-
Study protocol: CareAvenue program to improve unmet social risk factors and diabetes outcomes- A randomized controlled trial.Contemp Clin Trials. 2020 Feb;89:105933. doi: 10.1016/j.cct.2020.105933. Epub 2020 Jan 7. Contemp Clin Trials. 2020. PMID: 31923472 Free PMC article.
-
Use of health outcome and health service utilization indicators as an outcome of access to medicines in Brazil: perspectives from a literature review.Public Health Rev. 2019 Dec 9;40:5. doi: 10.1186/s40985-019-0115-1. eCollection 2019. Public Health Rev. 2019. PMID: 31867131 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical